Skip to main content
OpenTrials
Completed

NCT Number: NCT00714818

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Women with a close relative who has experienced mental illnesses like schizophrenia, bipolar disorder or schizoaffective disorder often have a poor understanding of the causes of the illness, and are often very worried about the chance that any children that they have will become affected with the same illness. Often, because of this fear, these healthy women choose not to have children.

Genetic counseling is a process where information about the causes of illnesses, and about chances for family members of individuals with these illnesses to become similarly affected is provided in a supportive environment by a specially trained healthcare professional. This study will investigate whether genetic counseling can reduce perceptions of risk and stigma, and increase perceived control and knowledge about the causes of the illness, amongst women who have a first degree relative with a major mental illness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Centre for Complex Disorders, BC Mental Health and Addictions Reserach Institute

Vancouver, British Columbia, V5A 4H4, Canada

About this study

We will recruit 75 women who have a close relative with a major psychiatric disorder (as defined above). Each participant will be randomized into one of 3 groups of approximately equal size: one of which will receive genetic counseling within 1 month after enrollment (GC), another will receive the educational brochure within 1 month (EB), and the last will be assigned to waitlist (WT). After randomization (but prior to intervention for GC and EB groups, and within 1 month after enrollment for the WT group) we will gather baseline information regarding the 4 outcome measures (perceived risk and control, stigma, and knowledge). We will re-assess the 4 outcome measures immediately post-intervention for GC and EB groups. A further follow-up (for all groups) will be conducted two months after enrollment (which is 1 month post intervention for GC and EB groups).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fluent in English, and
  • Have a first degree relative diagnosed with schizophrenia, bipolar, or schizoaffective disorder, and
  • Reside in BC, and be able to attend 3 study visits over 1.5 months

Treatment and study plan

Genetic Counseling

Behavioral

One face-to-face genetic counseling session of 1-2hours duration, with a board certified or board eligible genetic counselor which will involve, documentation of a detailed family history, discussion of: the contributors to mental illness pathogenesis, illness risk reduction strategies, chances for family members to develop mental illness (if required), supportive counseling around living with illness/risk of illness/managing illness vulnerability, and referral to support organizations as required

Primary outcomes

  1. knowledge

    Time frame: immediately post intervention and 1 month post intervention

  2. risk perception

    Time frame: immediately post intervention and 1 month post intervention

  3. stigma

    Time frame: immediately post intervention and 1 month post intervention

  4. perceived control

    Time frame: immediately post intervention and 1 month post intervention

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness: Impact on Knowledge, Risk Perception, Perceived Control and Internalized Stigma.

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
Jul 14, 2008
Registry last updated
Nov 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.